Ingen internetforbindelse — viser den gemte version af siden.

Medicus Pharma Lt…

USUSD
← Til Screeneren

Medicus Pharma Ltd. (US:MDCX) — Biotechnology: Pharmaceutical Preparations. Antal børser, hvor selskabets aktier handles: 1. På denne side — kurs og diagram, udbytte, største aktionærer og historik over antal aktier.

Om Virksomheden

Websted
medicuspharma.com
Investorrelationer
medicuspharma.com/investor-relations/press-releases/
Sektor
Health Care · Biotechnology: Pharmaceutical Preparations
Hovedkontor
W. CONSHOHOCKEN, United States
Administrerende Direktør
Raza Bokhari
Ansatte
16
Udestående Aktier
63.18 mio. pr. 2026-08-10
Free Float
52.61 mio.
Markedsværdi
138 068 USD
Insidere
22.6%
Institutionelle Investorer
4.15%
Branche (SIC)
Pharmaceutical Preparations
P/E
underskud
FCF
−29.3 mio. USD
Gæld
?
Indtjening og FCF — for de 12 måneder frem til 30.06.2026 (virksomhedens seneste rapport).
NAV
−0.03 USD
Balancedato30.06.2026
Aktiver27.1 mio. USD
− Forpligtelser28.8 mio. USD
= Total Egenkapital−1.72 mio. USD
− Ikke-Kontrollerende Interesser38.7 t. USD
= NAV (aktiekapital i selskabets aktionærer)−1.76 mio. USD
= Materiel NAV−1.76 mio. USD
Aktier60 168 044
NAV pr. Aktie−0.03 USD
Håndgribelig NAV pr. Aktie−0.03 USD
Egenkapitalen er negativ: forpligtelserne overstiger aktiverne (ofte på grund af store aktietilbagekøb). P/NAV beregnes ikke.
NAV-Historie
BalancedatoNAVNAV pr. Aktie
30.06.2026−1.76 mio. USD−0.03 USD
31.03.20261.33 mio. USD0.03 USD
31.12.2025−67.6 t. USD−0.00 USD
30.09.2025−910 t. USD−0.04 USD
31.12.20243.13 mio. USD0.27 USD
Beskrivelse

Medicus Pharma Ltd., a biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets in the United States. It is developing SKNJCT-003, which is in Phase 2 study for the treatment of basal cell carcinoma of the skin. The company has a strategic collaboration with the Gorlin Syndrome Alliance to access to SKINJECT in Patients with Gorlin Syndrome. The company was formerly known as Interactive Capital Partners Corporation and changed its name to Medicus Pharma Ltd. in September 2023. The company was incorporated in 2008 and is headquartered in West Conshohocken, Pennsylvania.

annonce

Børser og Tickere

BørsTickerValutaPrisType
US USA StocksMDCXUSD3.43 +9.94%almindelige aktier

Kurs over 3 Måneder

US:MDCX · USD
stigningsdag faldsdagHold musen over / tryk på en dag — åbnings-, luknings-, højeste og laveste kurs

Største Ejere

EjerAndelAktierRapportdato
BOKHARI RAZA (Chief Exec…≈4.65%2.94 mio.2026-09-04
Interchange Capital Part…2.51%1.59 mio.2026-06-30
BONNER CAROLYN F (Presid…≈2.36%1.49 mio.2026-09-04
MEHMUD FAISAL M.D. (Offi…≈2.33%1.47 mio.2026-09-04
SMITH ANDREW ALASDAIR (C…≈1.16%735 4582026-09-04
BRENNAN EDWARD JOSEPH JR…≈1.07%674 7352026-09-04
QUINLAN JAMES P (Chief F…≈0.84%528 2942025-08-13
Jane Street Group, LLC0.53%333 6732026-06-30
Xtx Topco Ltd0.39%243 3622026-06-30
Sterling Investment Advi…0.16%100 0002026-06-30
Commonwealth Equity Serv…0.08%52 6432026-06-30
May Hill Capital, LLC0.08%50 6222026-06-30
Susquehanna Internationa…0.05%31 4622026-06-30
Stifel Financial Corpora…0.05%30 0002026-06-30
Wilmington Savings Fund…0.04%25 6222026-06-30
JPMORGAN CHASE & CO0.04%25 6222026-06-30
EQ Advisors Trust-1290 V…0%2 7372026-03-31
VELOCITY FUND PARTNERS,…——2025-05-20